By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Oxford BioMedica PLC 

Medawar Centre
Robert Robinson Avenue

The Oxford Science Park
Oxford    OX4 4GA  United Kingdom
Phone: 01865-783000 Fax: 01865-783001



Gene Therapy

Company News
Oxford BioMedica (OXB.L) Announces A £2 Million Two-Year Collaboration Co-Funded By Innovate UK 8/14/2017 8:57:05 AM
Oxford BioMedica (OXB.L) Forges A $100 Million+ CAR-T Supply Deal With Novartis AG (NVS) 7/7/2017 6:31:12 AM
Oxford BioMedica PLC (OXB.L) Notes Findings On CTL019 From Phase II JULIET Study Presented At The 14th Meeting Of International Conference On Malignant Lymphoma (ICML) 6/15/2017 7:33:53 AM
Orchard Therapeutics Announces Strategic Alliance With Oxford BioMedica PLC (OXB.L) 11/29/2016 8:48:34 AM
Oxford BioMedica PLC (OXB.L) Announces Expanded Collaboration And Licence With Immune Design Corporation (IMDZ) 3/7/2016 9:33:42 AM
Oxford BioMedica PLC (OXB.L) Release: Interim Results For The Six Months Ended 30 June 2015 8/27/2015 9:11:24 AM
Oxford BioMedica PLC (OXB.L) Appoints Daniel Soland As Non-Executive Director To The Board 5/7/2015 9:36:09 AM
Oxford BioMedica PLC (OXB.L) Interim Management Statement 5/7/2015 8:57:31 AM
Oxford BioMedica PLC (OXB.L) Announces That A Summary Of The 12 Month And Three Year Follow Up Data From The Phase I/II Study With Prosavin Was Presented At The AANS Conference In The U.S. 5/5/2015 9:53:38 AM
Oxford BioMedica PLC (OXB.L) Secures $50 Million 5/1/2015 8:47:40 AM